Literature DB >> 20559691

Blocking gastrin and CCK-B autocrine loop affects cell proliferation and apoptosis in vitro.

Jian Jiang Zhou1, Man Ling Chen, Qun Zhou Zhang, Yan Zao, Yuan Xie.   

Abstract

Gastrin and cholecystokinin-B receptor (CCK-B) were co-expressed in human gastric carcinoma tissues, suggesting that a functional autocrine loop, the gastrin and CCK-B receptor loop, may be presented in gastric cancer cells and play an important role in the pathogenesis and progression of gastric carcinomas. The present study was aimed at studying the effects of blocking the gastrin and CCK-B receptor loop on cell proliferation and apoptosis in gastric cancer cell line SGC-7901 cells (SGC-7901 cells). First, the expression of gastrin and CCK-B receptor mRNAs and gastrin protein in SGC-7901 cells were measured by RT-PCR and immunocytochemistry, respectively. Radioimmunoassay (RIA) was used to detect the concentrations of gastrin in culture medium. The gastrin-CCK-B receptor axis was blocked by using a specific neutralizing antibody against human gastrin and siRNA specifically targeting human CCK-B receptors, respectively. Flow cytometry was used to measure the cell cycle and apoptotic cells, and western blotting was used to measure the expression of CCK-B receptor, caspase-3, and matrix metalloproteinase-2 (MMP-2) in cells. The results showed that SGC-7901 cells not only coexpressed gastrin and CCK-B receptor mRNAs, but also endogenously secreted gastrin protein into the culture medium, thus forming gastrin-CCK-B receptor autocrine loop. Biologically, disrupting gastrin-CCK-B receptor autocrine loop by neutralizing the endogenous gastrin or by knocking down CCK-B receptor expression significantly inhibited the cell proliferation and decreased the percentage of cells residing in the S-phase of the cell cycle, and meanwhile promoted cell apoptosis and increased caspase-3 expression as well as decreased MMP-2 expression. An autocrine loop between endogenously secreted gastrin and CCK-B receptors may play a key role in the regulation of cell proliferation and apoptosis in SGC-7901 cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20559691     DOI: 10.1007/s11010-010-0507-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  28 in total

Review 1.  Topical review. Gastrin and gastric epithelial physiology.

Authors:  G J Dockray
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

2.  Expression of some tumor associated factors in human carcinogenesis and development of gastric carcinoma.

Authors:  Ming-Dong Zhao; Xue-Mei Hu; Dian-Jing Sun; Qun Zhang; Yu-Hao Zhang; Wei Meng
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

Review 3.  Gastrin - active participant or bystander in gastric carcinogenesis?

Authors:  Susan A Watson; Anna M Grabowska; Mohamad El-Zaatari; Arjun Takhar
Journal:  Nat Rev Cancer       Date:  2006-12       Impact factor: 60.716

4.  Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer.

Authors:  John K Triantafillidis; Emmanuel Merikas; Vasillios Govosdis; Evangelia Konstandellou; Petros Cheracakis; Charalambos Barbatzas; Dimitrios Tzourmakliotis; George Peros
Journal:  Hepatogastroenterology       Date:  2003-12

5.  Gastrin-mediated activation of cyclin D1 transcription involves beta-catenin and CREB pathways in gastric cancer cells.

Authors:  Anamika Pradeep; Chandan Sharma; Pradeep Sathyanarayana; Chris Albanese; John V Fleming; Timothy C Wang; M Michael Wolfe; Kenneth M Baker; Richard G Pestell; Basabi Rana
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

6.  Gastrin regulates the heparin-binding epidermal-like growth factor promoter via a PKC/EGFR-dependent mechanism.

Authors:  Natalie F Sinclair; Wandong Ai; Raktima Raychowdhury; Meixia Bi; Timothy C Wang; Theodore J Koh; John T McLaughlin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02-05       Impact factor: 4.052

7.  Gastrin activates nuclear factor kappaB (NFkappaB) through a protein kinase C dependent pathway involving NFkappaB inducing kinase, inhibitor kappaB (IkappaB) kinase, and tumour necrosis factor receptor associated factor 6 (TRAF6) in MKN-28 cells transfected with gastrin receptor.

Authors:  M Ogasa; Y Miyazaki; S Hiraoka; S Kitamura; Y Nagasawa; O Kishida; T Miyazaki; T Kiyohara; Y Shinomura; Y Matsuzawa
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

8.  Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines.

Authors:  D F McWilliams; S A Watson; D M Crosbee; D Michaeli; R Seth
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

Review 9.  Gastrins, cholecystokinins and gastrointestinal cancer.

Authors:  Ahmad Aly; Arthur Shulkes; Graham S Baldwin
Journal:  Biochim Biophys Acta       Date:  2004-07-06

10.  Gastrin stabilises beta-catenin protein in mouse colorectal cancer cells.

Authors:  D H Song; J C Kaufman; L Borodyansky; C Albanese; R G Pestell; M Michael Wolfe
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

View more
  8 in total

1.  Downregulation of the CCK-B receptor in pancreatic cancer cells blocks proliferation and promotes apoptosis.

Authors:  Kristin K Fino; Gail L Matters; Christopher O McGovern; Evan L Gilius; Jill P Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-22       Impact factor: 4.052

2.  Gastrin receptor pharmacology.

Authors:  Graham J Dockray; Andy Moore; Andrea Varro; D Mark Pritchard
Journal:  Curr Gastroenterol Rep       Date:  2012-12

3.  MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2.

Authors:  Rui Zhang; Min Li; Wenqiao Zang; Xudong Chen; Yuanyuan Wang; Ping Li; Yuwen Du; Guoqiang Zhao; Li Li
Journal:  Tumour Biol       Date:  2013-08-23

4.  MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.

Authors:  Yong-Xi Song; Zhen-Yu Yue; Zhen-Ning Wang; Ying-Ying Xu; Yang Luo; Hui-Mian Xu; Xue Zhang; Li Jiang; Cheng-Zhong Xing; Yong Zhang
Journal:  Mol Cancer       Date:  2011-01-04       Impact factor: 27.401

5.  Anti-Gastrins Antiserum Combined with Lowered Dosage Cytotoxic Drugs to Inhibit the Growth of Human Gastric Cancer SGC7901 Cells in Nude Mice.

Authors:  Qing He; Hua Gao; Meng Gao; Shengmei Qi; Yingqi Zhang; Junzhi Wang
Journal:  J Cancer       Date:  2015-03-08       Impact factor: 4.207

6.  Gastrin/CCK-B Receptor Signaling Promotes Cell Invasion and Metastasis by Upregulating MMP-2 and VEGF Expression in Gastric Cancer.

Authors:  Yan Zhao; Qinrong Wang; Yi Zeng; Yuan Xie; Jianjiang Zhou
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

7.  MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer.

Authors:  Beiqin Yu; Xin Lv; Liping Su; Jianfang Li; Yingyan Yu; Qinlong Gu; Min Yan; Zhenggang Zhu; Bingya Liu
Journal:  PLoS One       Date:  2016-08-12       Impact factor: 3.240

8.  Gastrin: From Physiology to Gastrointestinal Malignancies.

Authors:  Suzann Duan; Karen Rico; Juanita L Merchant
Journal:  Function (Oxf)       Date:  2021-11-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.